HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Bone marrow mesenchymal stem cells offer an immune-privileged niche to Cutibacterium acnes in case of implant-associated osteomyelitis

Abstract : Considered as some of the most devastating complications, Cutibacterium acnes (C. acnes)-related osteomyelitis are among the hardest infections to diagnose and treat. Mesenchymal stem cells (MSCs) secrete number of immunomodulatory and antimicrobial soluble factors, making them an attractive treatment for bacterial infection. In this study, we examined MSCs/ C. acnes interaction and analyzed the subsequent MSCs and bacteria's behaviors. Human bone marrow-derived MSCs were infected by C. acnes clinical strain harvested from non-infected bone site. Following 3 h of interaction, around 4% of bacteria were found in the intracellular compartment. Infected MSCs increased the secretion of prostaglandin E2 and indolamine 2,3 dioxygenase immunomodulatory mediators. Viable intracellular bacteria analyzed by infrared spectroscopy and atomic force microscopy revealed deep modifications in the wall features. In comparison with unchallenged bacteria, the viable intracellular bacteria showed (i) an increase in biofilm formation on orthopaedical-based materials, (ii) an increase in the invasiveness of osteoblasts and (iii) persistence in macrophage, suggesting the acquisition of virulence factors. Overall, these results showed a direct impact of C. acnes on bone marrow-derived MSCs, suggesting that blocking the C. acnes /MSCs interactions may represent an important new approach to manage chronic osteomyelitis infections.
Document type :
Journal articles
Complete list of metadata

Contributor : Marius Colin Connect in order to contact the contributor
Submitted on : Monday, November 15, 2021 - 2:03:03 PM
Last modification on : Wednesday, March 16, 2022 - 3:47:06 AM
Long-term archiving on: : Wednesday, February 16, 2022 - 8:39:06 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2022-11-15

Please log in to resquest access to the document



Marie Dubus, Jennifer Varin-Simon, Steve Papa, Julie Chevrier, Fabienne Quilès, et al.. Bone marrow mesenchymal stem cells offer an immune-privileged niche to Cutibacterium acnes in case of implant-associated osteomyelitis. Acta Biomaterialia, Elsevier, 2022, 137, pp.305-3015. ⟨10.1016/j.actbio.2021.10.026⟩. ⟨hal-03418156⟩



Record views